Review of Autism Profiles and Response to Sertraline in Fragile X Syndrome-Associated Autism vs. Non-syndromic Autism; Next Steps for Targeted Treatment

Given significant genetic, molecular, and phenotypic overlaps, researchers have begun to investigate whether targeted treatments for Fragile X Syndrome (FXS) could also be beneficial for patients with Autism Spectrum Disorder (ASD). For example, low-dose sertraline, an SSRI, was used in two recent c...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajaratnam, Akash, Potter, Laura Axelrod, Biag, Hazel Maridith Barlahan, Schneider, Andrea, Petrasic, Ignacio Cortina, Hagerman, Randi Jenssen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661746/
https://www.ncbi.nlm.nih.gov/pubmed/33193037
http://dx.doi.org/10.3389/fneur.2020.581429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661746/
https://www.ncbi.nlm.nih.gov/pubmed/33193037
http://dx.doi.org/10.3389/fneur.2020.581429

Ejemplares similares